Sperm protein 17 is highly expressed in endometrial and cervical cancers
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics,Oncology
Link
http://link.springer.com/content/pdf/10.1186/1471-2407-10-429.pdf
Reference33 articles.
1. Irvin WP, Rice LW, Berkowitz RS: Advances in the management of endometrial adenocarcinoma. J Reprod Med. 2002, 47: 173-190.
2. Waggoner SE: Cervical cancer. Lancet. 2003, 361: 2217-2225. 10.1016/S0140-6736(03)13778-6.
3. Lea IA, Richardson RT, Widgren EE, O'Rand MG: Cloning and sequencing of cDNAs encoding the human sperm protein, Sp17. Biochim Biophys Acta. 1996, 1307: 263-266.
4. Wen Y, Richardson RT, Widgren EE, O'Rand MG: Characterization of Sp17: A ubiquitous three-domain protein that binds heparin. Biochem J. 2001, 357: 25-31. 10.1042/0264-6021:3570025.
5. Lacy HM, Sanderson RD: Sperm protein 17 is expressed on normal and malignant lymphocytes and promotes heparan sulfate-mediated cell-cell adhesion. Blood. 2001, 98: 2160-2165. 10.1182/blood.V98.7.2160.
Cited by 25 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Enhanced Electrochemical Biosensing of the Sp17 Cancer Biomarker in Serum Samples via Engineered Two-Dimensional MoS2 Nanosheets on the Reduced Graphene Oxide Interface;ACS Applied Bio Materials;2023-09-16
2. Fabrication of alkoxysilane substituted polymer-modified disposable biosensing platform: Towards sperm protein 17 sensing as a new cancer biomarker;Talanta;2022-06
3. Sperm Autoantigenic Protein 17 Predicts the Prognosis and the Immunotherapy Response of Cancers: A Pan-Cancer Analysis;Frontiers in Immunology;2022-05-03
4. The interplay of immunotherapy, chemotherapy, and targeted therapy in tripple negative breast cancer (TNBC);Combinational Therapy in Triple Negative Breast Cancer;2022
5. Sperm protein 17 targeting for epithelial ovarian cancer treatment in the era of modern immunoengineering;Molecular Therapy - Oncolytics;2021-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3